Centene Corp Names New CFO, Reaffirms 2026 EPS Guidance

What Happened

• Centene Corporation announced on Aug 17, 2026 that CFO Andrew Asher will retire as Chief Financial Officer effective Dec 31, 2026 and will serve as Strategic Advisor through the end of 2027 reporting to CEO Sarah M. London.
• The company identified Christopher Neczypor as Asher’s successor, expected to become Executive Vice President and Chief Financial Officer effective Jan 1, 2027; Neczypor will begin as Executive Vice President on or about Sept 1, 2026 (initially not a Section 16 officer).
• Centene also reaffirmed its full‑year 2026 adjusted diluted EPS guidance of greater than $4.80 and all associated 2026 full‑year guidance metrics announced July 28, 2026.

Key Details

• Neczypor (age 45) was CFO of Lincoln National (Feb 2023–Aug 2026) and holds a bachelor’s in finance and accounting from Lehigh University.
• Compensation package: $1,100,000 base salary; target annual cash bonus 150% of base (up to 200% possible); 2027 long‑term equity awards up to $5,250,000 (target value).
• Make‑whole compensation: $10,000,000 in restricted stock units (vests in three equal annual installments) and a $2,000,000 cash sign‑on (repayable if he leaves without “good reason” or is fired for “cause” within 12 months).
• Severance and participation in senior executive benefit plans apply if terminated without cause or if he departs for good reason, subject to a release of claims.

Why It Matters

• Leadership transition: Naming an experienced insurance‑industry CFO provides continuity for Centene’s financial leadership ahead of 2027, with a planned overlap and advisory support from the outgoing CFO.
• Financial impact: One‑time make‑whole awards and ongoing equity/grant packages are material compensation items that could affect future non‑cash expense and share dilution.
• Guidance reaffirmation: Management’s reaffirmation of >$4.80 adjusted diluted EPS for 2026 signals confidence in near‑term earnings outlook and helps reduce uncertainty for investors monitoring results.